Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
AUPH Aurinia Pharmaceuticals
- 8.230
- +0.060+0.73%
Trading Mar 11 10:46 ET
1.13BMarket Cap205.75P/E (TTM)
8.360High8.130Low446.61KVolume8.230Open8.170Pre Close3.69MTurnover0.34%Turnover Ratio205.75P/E (Static)137.34MShares10.67052wk High2.99P/B1.10BFloat Cap4.71052wk Low--Dividend TTM133.30MShs Float33.972Historical High--Div YieldTTM2.82%Amplitude1.000Historical Low8.263Avg Price1Lot Size
About Aurinia Pharmaceuticals Company
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
Company Profile
SymbolAUPH
Company NameAurinia Pharmaceuticals
Listing DateFeb 25, 2000
Founded1993
CEOMr. Peter S. Greenleaf
MarketNASDAQ
Employees130
Fiscal Year Ends12-31
Address14315 – 118 Avenue,Suite 140
CityEdmonton
ProvinceAlberta
CountryCanada
Zip CodeT5L 4S6
Phone1-250-744-2487
Websitehttp://www.auriniapharma.com
Company Executives
- Name
- Position
- Salary
- Peter S. Greenleaf
- President, Chief Executive Officer and Director
- 10.57M
- Joseph M. Miller
- Chief Financial Officer and Principal Accounting Officer
- 3.98M
- Stephen P. Robertson
- Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
- 3.60M
- Matthew Donley
- Executive Vice President, Operations and Strategy
- 4.56M
- Craig A. Johnson
- Director
- --
- Kevin C. Tang
- Director
- --
- Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
- Independent Director
- 359.41K
- Jill D. Leversage
- Independent Director
- 267.28K
- Jeffrey Allen Bailey
- Independent Director
- 361.51K
- Dr. David R.W. Jayne, F.R.C.P.,M.D.
- Independent Director
- 249.92K